In this episode, we sit down with leading researchers working on the front lines of Pennsylvania’s medical marijuana program to explore what cannabis reclassification really means for research, medicine, and patient care.
Featuring Stephen E. Lankenau, PhD (Director of the Medical Cannabis Research Center), Dr. Raup-Konsavage of Penn State, and Mark Kelley (LECOM’s Medical Marijuana Research Program), the conversation unpacks Pennsylvania’s unique model that allows medical schools to partner with cannabis providers to conduct clinical research.
